X BODY
Waltham
About X BODY
X-BODY is a biotechnology company that discovers and develops compounds against targets in oncology and ophthalmology. The company's mission is to apply its innovative capabilities to the discovery of human antibodies against high-value therapeutic targets. X-BODY has entered into a number of alliances with other corporations to generate antibody therapeutic candidates. X-BODY's internal efforts are focused on discovering and developing compounds against biologically relevant targets in oncology and ophthalmology. X-BODY was formed in 2008 by industry veterans Richard Wagner, Brant Binder, and Gordon Binder.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $6.8M
- Funding stage: M&A
- Last round: Series Unknown (Feb 2013)
- Website: x-bodybiosciences.com
- Phone: (781) 419-6990
Industries & Categories
Biotechnology, Developer Platform, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/x-body-911003 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.